Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
NEULANDLAB Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Analysts have been raising forward EPS estimates
Low Debt to Equity, not much change from last year
Consistently pays dividend
Negative
Expensive and at a premium to industry median P/E
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
High ROE but declining trend
High operating margin but declining trend
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
NEULANDLAB Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
NEULANDLAB Bulk, Block & Insider Trades
NEULANDLAB Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Rights issue
Rights issue(4 new shares @ 204 INR for 25 existing shares) Ex-date: 13th Aug 2014 Announced on: 4th Aug 2014
Rights issue(5 new shares @ 45 INR for 12 existing shares)Offer price inclusive of premium of INR 35. Ex-date: 21st Mar 2012 Announced on: 7th Jul 2011
Rights issue(1 new shares @ 60 INR for 2 existing shares) Ex-date: 24th Jan 1996 Announced on: 28th Nov 1995
Company Profile
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical... Read More
Key personnel
Dr. Davuluri Rama Mohan RaoD
Executive Chairman of the Board
Mr. Davuluri Sucheth RaoD
Executive Vice Chairman of the Board
Mr. Davuluri Saharsh RaoD
Chief Executive Officer, Managing Director
Mr. Abhijit Majumdar
Chief Financial Officer
Dr. Sharadsrikar V. (Sharad) Kotturi
Chief Scientific Officer
Ms. Sarada Bhamidipati
Compliance Officer, Company Secretary
Mr. Ashutosh Kumar Sinha
Chief Quality Officer
Dr. Christopher M. CimarustiD
Non-Executive Non-Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Neuland Laboratories Ltd.?
The current share price of Neuland Laboratories Ltd. is ₹ 14,775.30 as of 09 Jan 2026.
What is the PE ratio of Neuland Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Neuland Laboratories Ltd. is 78.94 as of the latest financial data.
What is the ROE and ROCE of Neuland Laboratories Ltd.?
Neuland Laboratories Ltd. has a Return on Equity (ROE) of 15.93% and a Return on Capital Employed (ROCE) of 9.73% as per the latest financial reports.
What is the market cap of Neuland Laboratories Ltd.?
The market capitalization of Neuland Laboratories Ltd. stands at ₹ 18,956.70 Cr.
What is the dividend yield of Neuland Laboratories Ltd.?
The dividend yield of Neuland Laboratories Ltd. is 0.08% based on the current market price.
What is the RSI of Neuland Laboratories Ltd.?
The Relative Strength Index (RSI) of Neuland Laboratories Ltd. is 39.64.
What is the FII and DII holding in Neuland Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 20.90% and Domestic Institutional Investors (DII) hold 11.57% of Neuland Laboratories Ltd. shares.
What sector does Neuland Laboratories Ltd. belong to?
Neuland Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Neuland Laboratories Ltd. stock?
The beta of Neuland Laboratories Ltd. stock is 1.29, indicating its volatility relative to the broader market.
